Peter Sjö
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
-
- Computational Drug Discovery Methods
Papers in
-
- SARS-CoV-2 and COVID-19 Research 4
-
- Asymmetric Synthesis and Catalysis 2
- Free Radicals and Antioxidants 2
- Co-authors
- K. Barry Sharpless (1 shared paper)Kyu‐Sung Jeong (1 shared paper)Lena Ripa (4 shared papers)Igor L. Shamovsky (4 shared papers)Mike O’Donovan (2 shared papers)Stefan Schießer (3 shared papers)Peter Hansen (2 shared papers)Jan Kihlberg (3 shared papers)
- Journals
- Journal of Medicinal Chemistry (2 papers)Chemical Research in Toxicology (2 papers)Journal of the American Chemical Society (1 paper)Chemical Communications (1 paper)Tetrahedron Letters (1 paper)
- Partner nations
- SwitzerlandSwedenUnited Kingdom
In The Last Decade
Peter Sjö
20 papers receiving 503 citations
Peers
Comparison fields: 5 of 92
- Infectious Diseases 150
- Computational Theory and Mathematics 107
- Organic Chemistry 143
- Pharmacology 38
- Molecular Biology 206
Countries citing papers authored by Peter Sjö
This map shows the geographic impact of Peter Sjö's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Sjö with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Sjö more than expected).
Fields of papers citing papers by Peter Sjö
This network shows the impact of papers produced by Peter Sjö. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Sjö. The network helps show where Peter Sjö may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Sjö, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 84 | |
| 2 | 2023 | 66 | |
| 3 | 2011 | 59 | |
| 4 | 1992 | 51 | |
| 5 | 2023 | 34 | |
| 6 | 2018 | 34 | |
| 7 | 2020 | 33 | |
| 8 | 2012 | 26 | |
| 9 | 2012 | 22 | |
| 10 | 2022 | 20 | |
| 11 | 2014 | 18 | |
| 12 | 2017 | 15 | |
| 13 | 2020 | 14 | |
| 14 | 2010 | 10 | |
| 15 | 2017 | 10 | |
| 16 | 2018 | 7 | |
| 17 | 2022 | 7 | |
| 18 | 1993 | 3 | |
| 19 | 2024 | 2 | |
| 20 | 2023 | 1 |
About Peter Sjö
Peter Sjö is a scholar working on Infectious Diseases, Organic Chemistry, Molecular Biology, Public Health, Environmental and Occupational Health and Computational Theory and Mathematics, having authored 20 papers that have together received 516 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), Computational Drug Discovery Methods (3 papers), Metal-Catalyzed Oxygenation Mechanisms (3 papers), Asymmetric Synthesis and Catalysis (2 papers), Microbial Natural Products and Biosynthesis (2 papers), Free Radicals and Antioxidants (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Research on Leishmaniasis Studies (2 papers). The work is most often cited by research in Infectious Diseases (150 citations), Computational Theory and Mathematics (107 citations), Organic Chemistry (143 citations), Pharmacology (38 citations) and Molecular Biology (206 citations). Peter Sjö has collaborated with scholars based in Switzerland, Sweden and United Kingdom. Frequent co-authors include K. Barry Sharpless, Kyu‐Sung Jeong, Lena Ripa, Igor L. Shamovsky, Mike O’Donovan, Stefan Schießer, Peter Hansen, Jan Kihlberg, Bo Nordén and Charles E. Mowbray. Their work appears in journals such as Journal of Medicinal Chemistry, Chemical Research in Toxicology, Journal of the American Chemical Society, Chemical Communications and Tetrahedron Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.